Dr. Sharlene Gill is a medical oncologist specializing in gastrointestinal (GI) malignancies. She received a Bachelor’s of Science in Pharmacy (Honors) and an MD (Doctor of Medicine) from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Master’s of Public Health from the Harvard School of Public Health (Boston, MA) before returning to Vancouver, Canada where she is presently a Professor of Medicine at the University of British Columbia and staff oncologist at the BC Cancer Agency.
Dr. Gill’s areas of expertise are colorectal, pancreatic and hepatobiliary cancers. In addition to her clinical work, she is actively engaged in education and research, with over 80 peer-reviewed publications and book chapters to her credit. She is currently an MBA Candidate at Kenan-Flagler Business School (University of North Carolina, Class of 2017).
Areas of specialization: GI cancers, development of novel therapies, medical education